Announcements Trials

Browse Landscape

Phase

Phase 4 2 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rare Diseases 1 Lung Neoplasms 1 Graft vs Host Disease 1 Gastrointestinal Diseases 1 Fatigue 1 Crohn Disease 1 Colitis, Ulcerative 1 Carcinoma, Non-Small-Cell Lung 1 Cachexia 1 Bronchiolitis Obliterans Syndrome 1 Anorexia 1

Interventions

etrolizumab 5 Adalimumab 2 Ringer's Lactate 1 Mesalamine 1 Loperamide 1 Injections 1 Infliximab 1 Hydroxyethyl Starch Derivatives 1 Andrographis paniculata extract 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colitis, Ulcerative × Infliximab × Clear all

NCT02136069 2021-12-03

GARDENIA

Hoffmann-La Roche

Phase 3 Completed

397 enrolled 32 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡